Caissa Capital Management ltd. - 17 Apr 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Issuer symbol
AVTX
Transactions as of
17 Apr 2023
Net transactions value
+$73,874
Form type
4
Filing time
18 Apr 2023, 16:08:00 UTC
Previous filing
11 Apr 2023
Next filing
24 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $44,436 +15,000 +1.2% $2.96* 1,282,700 17 Apr 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $29,438 +10,000 +0.78% $2.94* 1,292,700 18 Apr 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182,300 17 Apr 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $3.09, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.82 to $3.01, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.